Bosnalijek
Company type | Public (SASE: BSNLR) |
---|---|
Industry | Pharmaceutical |
Founded | 1951 |
Headquarters | Sarajevo, Bosnia and Herzegovina |
Key people | Adnan Hadžić (General director) |
Products | Solid oral form medicines, ampule medicines, galenic products, non-pharmaceutical chemical products |
Revenue | €80.91 million (2018[1]) |
€6.62 million (2018[1]) | |
Total assets | €157.01 million (2018[1]) |
Total equity | €91.00 million (2018[1]) |
Owner | Haden S.A. (25.95%) KBC Euro Credit Capital (23.68%) Economic and Social Development Fund (7.60%) Others |
Number of employees | 720 (2019[2]) |
Website | http://www.bosnalijek.ba/ |
Bosnalijek is a Bosnian pharmaceutical company headquartered in Sarajevo, Bosnia and Herzegovina. Established in 1951, it is the largest pharmaceutical company in Bosnia and Herzegovina, present in more than 20 markets and having annual revenue of around 80 million euros (as of 2018).
History
Bosnalijek was established in 1951 in Sarajevo, FPR Yugoslavia, present-day Bosnia and Herzegovina.[citation needed]
In 2005, the International Finance Corporation provided Bosnalijek with a €7.5 million loan for the construction of an €18.5 million production and distribution center.[3]
In August 2016, Bosnalijek celebrated its 65-year anniversary.[4] In October 2016, the Government of the Federation of Bosnia and Herzegovina sold its remaining shares in the company in the auction.[5]
As of 2019, Bosnalijek is presented in more than 20 markets, with revenues from foreign markets accounting for 76% of all revenues.[6]
References
- ^ a b c d "Report on Company operations in 4th quarter 2018" (PDF). bosnalijek.com (in Bosnian). Retrieved 9 June 2019.
- ^ "BOSNALIJEK D.D. SARAJEVO Opće informacije". sase.ba (in Bosnian). Retrieved 9 June 2019.
- ^ Summary of Project Information, Project Number 24017[permanent dead link], International Finance Corporation, World Bank Group. Accessed 2008-01-14.
- ^ "Bosnalijek slavi 65 godina uspješnog rada". klix.ba (in Bosnian). 14 August 2016. Retrieved 9 June 2019.
- ^ "Bosnia region sells stake in drugmaker Bosnalijek for $13.4 mln". reuters.com. 6 October 2016. Retrieved 9 June 2019.
- ^ "Uzunović: Najveći dio prihoda od prodaje Bosnalijek realizira van BiH". biznis.ba (in Bosnian). 12 May 2019. Retrieved 9 June 2019.
External links
- Media related to Bosnalijek at Wikimedia Commons
- CS1 Bosnian-language sources (bs)
- All articles with dead external links
- Articles with dead external links from November 2016
- Articles with permanently dead external links
- Use dmy dates from October 2023
- All articles with unsourced statements
- Articles with unsourced statements from October 2023
- Commons category link is on Wikidata
- Pharmaceutical companies established in 1951
- Companies based in Sarajevo
- Pharmaceutical companies of Bosnia and Herzegovina
- 1951 establishments in Yugoslavia
- Brands of Bosnia and Herzegovina
- All stub articles
- European company stubs